Abstract:Background Prostate cancer is one of the leading causes of cancer death in men. Androgen ablation, the most commonly-used therapy for progressive prostate cancer, is ineffective once the cancer cells become androgen-independent. The regulatory mechanisms that cause this transition (from androgen-dependent to androgen-independent) remain unknown. In this study, based on the microarray data comparing global gene expression patterns in the prostate tissue between androgen-dependent and -independent prostate cancer patients, we indentify a set of transcription factors and microRNAs that potentially cause such difference, using a model-based computational approach. Results From 335 position weight matrices in the TRANSFAC database and 564 microRNAs in the microRNA registry, our model identify 5 transcription factors and 7 microRNAs to be potentially responsible for the level of androgen dependency. Of these transcription factors and microRNAs, the estimated function of all the 5 transcription factors are predicted to be inhibiting transcription in androgen-independent samples comparing with the dependent ones. Six out of 7 microRNAs, however, demonstrated stimulatory effects. We also find that the expression levels of three predicted transcription factors, including AP-1, STAT3 (signal transducers and activators of transcription 3), and DBP (albumin D-box) are significantly different between androgen-dependent and -independent patients. In addition, microRNA microarray data from other studies confirm that several predicted microRNAs, including miR-21, miR-135a, and miR-135b, demonstrate differential expression in prostate cancer cells, comparing with normal tissues. Conclusion We present a model-based computational approach to identify transcription factors and microRNAs influencing the progression of androgen-dependent prostate cancer to androgen-independent prostate cancer. This result suggests that the capability of transcription factors to initiate transcription and microRNAs to facilitate mRNA degradation are both decreased in androgen-independent prostate cancer. The proposed model-based approach indicates that considering combinatorial effects of transcription factors and microRNAs in a unified model provides additional transcriptional and post-transcriptional regulatory mechanisms on global gene expression in the prostate cancer with different hormone-dependency.

The Transcription Factor NF-kB1 Regulates Mir-195 Expression in Prostate Cancer

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Mir199b Suppresses Expression Of Hypoxia-Inducible Factor 1 Alpha (Hif-1 Alpha) In Prostate Cancer Cells

Downregulation of Mir-195 Promotes Prostate Cancer Progression by Targeting HMGA1.

The Effect of the Overexpression of Mir-490 on the Biological Function of Prostate Cancer Cell PC-3

Tumor-suppressive Microrna-497 Targets IKKβ to Regulate NF-κB Signaling Pathway in Human Prostate Cancer Cells.

Mir-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells

Twist1/Dnmt3a and Mir186 Establish a Regulatory Circuit That Controls Inflammation-Associated Prostate Cancer Progression

Mir-503 Suppresses Tumor Cell Proliferation and Metastasis by Directly Targeting RNF31 in Prostate Cancer

Transcription Factor and Microrna Regulation in Androgen-Dependent and -Independent Prostate Cancer Cells

Downregulation of Mir-199A-5p Promotes Prostate Adeno-Carcinoma Progression Through Loss of Its Inhibition of HIF-1α.

Transcriptional Regulation of PRKAR2B by Mir-200B-3p/200c-3p and XBP1 in Human Prostate Cancer.

MicroRNA-195-5p, a New Regulator of Fra-1, Suppresses the Migration and Invasion of Prostate Cancer Cells

MicroRNA-195-5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1

Mir-892b Silencing Activates Nf-Kappa B And Promotes Aggressiveness In Breast Cancer

MicroRNA‐19a Regulates Proliferation and Apoptosis of Castration‐resistant Prostate Cancer Cells by Targeting BTG1

Genome-wide Screening Reveals That Mir-195 Targets the TNF-α/NF-κB Pathway by Down-Regulating IκB Kinase Alpha and TAB3 in Hepatocellular Carcinoma.

Additional File 10: Figure S6. of Downregulation of Mir-141-3p Promotes Bone Metastasis Via Activating NF-ÎşB Signaling in Prostate Cancer

Mir-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis.

Microrna145 Targets Bnip3 And Suppresses Prostate Cancer Progression

Mir-181a-5p Is Downregulated And Inhibits Proliferation And The Cell Cycle In Prostate Cancer